Clinuvel Pharmaceuticals Limited
ASX:CUV.AX
14.8 (AUD) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 88.178 | 78.321 | 65.722 | 47.976 | 32.565 | 31.048 | 25.486 | 16.765 | 6.82 | 3.318 | 2.663 | 1.553 | 0.723 | 1.041 | 0 | 0 | 0 | 0.283 | 0.755 | 0.125 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 10.081 | 27.732 | 19.105 | 12.771 | 14.134 | 0.445 | 0.95 | 0.615 | 1.936 | 5.908 | 0.372 | 0.166 | 0 | 0 | 0 | 0.917 | 0.945 | 0.957 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 78.097 | 50.589 | 46.617 | 35.205 | 18.431 | 30.602 | 24.536 | 16.15 | 4.884 | -2.591 | 2.291 | 1.387 | 0.723 | 1.041 | 0 | -0.917 | -0.945 | -0.674 | 0.755 | 0.125 | 0 | 0 | 0 | 0 | 0 |
| Brutowinstmarge
| 0.886 | 0.646 | 0.709 | 0.734 | 0.566 | 0.986 | 0.963 | 0.963 | 0.716 | -0.781 | 0.86 | 0.893 | 1 | 1 | 0 | 0 | 0 | -2.379 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 2.348 | 1.268 | 1.233 | 0.548 | 0.341 | 0.091 | 0.054 | 0.13 | 0.133 | 0.232 | 2.944 | 4.022 | 4.892 | 7.19 | 7.422 | 9.992 | 6.112 | 4.469 | 4.001 | 5.221 | 5.539 | 0.949 | 0.373 | 0.463 | 0 |
| Algemene en administratieve kosten
| 25.025 | 1.323 | 1.147 | 1.095 | 1.148 | 4.783 | 6.685 | 4.882 | 5.591 | 10.508 | 4.541 | 4.516 | 4.657 | 4.918 | 5.832 | 6.21 | 8.176 | 4.527 | 4.644 | 3.162 | 1.766 | 1.352 | 1.008 | 0.428 | 0 |
| Verkoop- en marketingkosten
| 0 | 7.088 | 11.154 | 6.866 | 1.889 | 1.502 | 1.051 | 0.811 | 0.778 | 0.802 | 0.516 | 0.603 | 0.806 | 0.626 | 0.704 | 0.846 | 1.415 | 1.655 | 1.08 | 0.884 | 0.641 | 0.118 | 0.108 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 25.025 | 8.411 | 12.301 | 7.961 | 7.893 | 6.285 | 6.336 | 5.298 | 4.699 | 5.633 | 4.863 | 5.119 | 5.463 | 5.544 | 6.536 | 7.056 | 9.591 | 6.183 | 5.723 | 4.046 | 2.406 | 1.47 | 1.116 | 0.428 | 0 |
| Overige kosten
| -0.197 | 0.763 | 0.821 | -1.236 | 0.781 | 0.88 | 0.486 | 0.096 | 0.797 | 0.47 | 0.44 | 1.009 | -0.095 | 0.046 | 2.667 | -0.68 | -0.945 | -0.925 | 3.797 | 6.342 | 0.926 | 2.488 | 0.748 | -0.775 | 0 |
| Bedrijfskosten
| 30.091 | 9.68 | 13.534 | 8.509 | 8.234 | 13.031 | 11.836 | 9.3 | 8.246 | 8.172 | 8.143 | 9.834 | 11.029 | 13.772 | 16.378 | 18.192 | 18.849 | 11.557 | 11.657 | 12.454 | 8.735 | 4.907 | 4.147 | 0.036 | 0 |
| Bedrijfsresultaat
| 55.133 | 40.91 | 33.083 | 26.696 | 10.197 | 16.691 | 12.215 | 6.799 | -3.55 | -10.827 | -5.83 | -8.281 | -10.306 | -12.731 | -16.378 | -18.192 | -18.849 | -11.274 | -10.902 | -12.33 | -8.735 | -4.907 | -4.185 | -1.966 | 0 |
| Bedrijfsresultaat ratio
| 0.625 | 0.522 | 0.503 | 0.556 | 0.313 | 0.538 | 0.479 | 0.406 | -0.52 | -3.263 | -2.189 | -5.332 | -14.259 | -12.229 | 0 | 0 | 0 | -39.794 | -14.443 | -98.938 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| -0.197 | 4.669 | 1.238 | -0.983 | 1.344 | 1.424 | 0.728 | 0.315 | 0.396 | 0.413 | 0.304 | 1.009 | -0.095 | 0.046 | 2.667 | -0.68 | -0.945 | -1.046 | -1.229 | 6.311 | 0.922 | 0.931 | 0.748 | -0.775 | 0 |
| Inkomen voor belasting
| 50.679 | 45.579 | 34.321 | 25.713 | 11.541 | 18.115 | 12.942 | 7.114 | -3.154 | -10.414 | -5.526 | -6.803 | -9.767 | -11.409 | -11.521 | -15.373 | -14.656 | -9.176 | -10.769 | -11.029 | -7.59 | -3.977 | -3.141 | -1.558 | -0.374 |
| Inkomen voor belasting ratio
| 0.575 | 0.582 | 0.522 | 0.536 | 0.354 | 0.583 | 0.508 | 0.424 | -0.462 | -3.139 | -2.075 | -4.38 | -13.513 | -10.96 | 0 | 0 | 0 | -32.389 | -14.266 | -88.5 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 15.043 | 14.974 | 13.442 | 0.984 | -3.51 | 0.019 | 0.282 | -0.045 | -0.609 | -0.016 | 0 | -0.468 | -0.634 | -1.276 | -2.19 | -3.498 | -5.139 | -3.023 | -0.133 | -11.029 | -7.59 | -3.977 | -3.141 | -1.558 | -0.374 |
| Nettowinst
| 35.636 | 30.605 | 20.878 | 24.728 | 16.647 | 18.134 | 13.224 | 7.181 | -3.121 | -10.398 | -5.526 | -6.803 | -9.767 | -11.409 | -11.521 | -15.373 | -14.656 | -9.176 | -10.769 | -11.029 | -7.59 | -3.977 | -3.141 | -1.558 | 0 |
| Nettowinstmarge
| 0.404 | 0.391 | 0.318 | 0.515 | 0.511 | 0.584 | 0.519 | 0.428 | -0.458 | -3.134 | -2.075 | -4.38 | -13.513 | -10.96 | 0 | 0 | 0 | -32.389 | -14.266 | -88.5 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| 0.71 | 0.62 | 0.42 | 0.5 | 0.31 | 0.38 | 0.28 | 0.15 | -0.069 | -0.24 | -0.14 | -0.19 | -0.32 | -0.38 | -0.38 | -0.51 | -0.48 | -0.37 | -0.64 | -0.84 | -0.66 | -0.44 | -0.35 | -0.22 | -0.041 |
| Verwaterde WPA
| 0.69 | 0.59 | 0.4 | 0.48 | 0.3 | 0.37 | 0.27 | 0.14 | -0.069 | -0.24 | -0.14 | -0.19 | -0.32 | -0.38 | -0.38 | -0.51 | -0.48 | -0.37 | -0.64 | -0.84 | -0.66 | -0.44 | -0.35 | -0.22 | -0.041 |
| EBITDA
| 56.276 | 41.699 | 33.841 | 27.558 | 10.643 | 16.782 | 12.259 | 6.852 | -3.524 | -10.8 | -5.792 | -8.223 | -10.244 | -12.639 | -15.662 | -17.361 | -18.007 | -10.248 | -8.759 | -11.506 | -7.945 | -4.113 | -3.361 | -2.332 | 0 |
| EBITDA ratio
| 0.638 | 0.532 | 0.515 | 0.574 | 0.327 | 0.541 | 0.481 | 0.409 | -0.517 | -3.255 | -2.175 | -5.295 | -14.172 | -12.141 | 0 | 0 | 0 | -36.172 | -11.603 | -92.327 | 0 | 0 | 0 | 0 | 0 |